Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”

Kebabian, J. W., Petzold, G. L., & Greengard, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.8.2145 · Cited by 1,025 · see citing works

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869 · see citing works

Drugs, Neurotransmitters, and Schizophrenia

Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. A. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834 · see citing works

Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

Seeman, P. M., Chau-Wong, M., Tedesco, J., & Wong, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4376 · Cited by 702 · see citing works

Membrane Receptors

Cuatrecasas, P. (1974) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.43.070174.001125 · Cited by 642 · see citing works

Dopamine-Sensitive Adenylate Cyclase in Mammalian Brain: A Possible Site of Action of Antipsychotic Drugs

Clement‐Cormier, Y. C., Kebabian, J. W., Petzold, G. L., & Greengard, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1113 · Cited by 452 · see citing works

On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholine

Karlin, A. (1967) · Journal of Theoretical Biology · doi:10.1016/0022-5193(67)90011-2 · Cited by 433 · see citing works

Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol

Creese, I., Burt, D. R., & Snyder, S. H. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90454-3 · Cited by 389 · see citing works

IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Janssen, P. A., Cj, N., & Schellekens, K. H. L. (1965) · PubMed · Cited by 348 · see citing works

The Action of Neuroleptic Drugs on Dopamine-Stimulated Adenosine Cyclic 3',5'-Monophosphate Production in Rat Neostriatum and Limbic Forebrain

Miller, R. J., Horn, A. S., & Iversen, L. L. (1974) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13988-6 · Cited by 256 · see citing works

Dopamine receptor binding in the corpus striatum of mammalian brain.

Burt, D. R., Enna, S. J., Creese, I., & Snyder, S. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4655 · Cited by 220 · see citing works

Chlorpromazie and Dopamine: Conformational Similarities that Correlate with the Antischizophrenic Activity of Phenothiazine Drugs

Horn, A. S., & Snyder, S. H. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.10.2325 · Cited by 199 · see citing works

The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states

Creese, I., Burt, D. R., & Snyder, S. H. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90118-6 · Cited by 169 · see citing works

Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.

Janssen, P. A., Cj, N., Schellekens, K. H. L., et al. (1968) · PubMed · Cited by 164 · see citing works

On the excitability and cooperativity of the electroplax membrane.

Changeux, J., & Podleski, T. R. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.59.3.944 · Cited by 161 · see citing works

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.

Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., & Lenaerts, F. M. (1967) · PubMed · Cited by 134 · see citing works

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?

Janssen, P. A., Cj, N., & Schellekens, K. H. L. (1966) · PubMed · Cited by 127 · see citing works

Antipsychotic Drugs and Dopamine-Stimulated Adenylate Cyclase Prepared from Corpus Striatum of Rat Brain

Karobath, M. E., & Leitich, H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.7.2915 · Cited by 102 · see citing works

Phenothiazine drugs: structure-activity relationships explained by a conformation that mimics dopamine.

Feinberg, A. P., & Snyder, S. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1899 · Cited by 89 · see citing works

Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain

von Hungen, K., Roberts, S., & Hill, D. F. (1975) · Brain Research · doi:10.1016/0006-8993(75)90876-8 · Cited by 71 · see citing works

Neurotransmitter and drug receptors in the brain

Snyder, S. H. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90358-5 · Cited by 71 · see citing works

The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug

Voith, K., & Herr, F. (1975) · Psychopharmacology · doi:10.1007/bf00428819 · Cited by 36 · see citing works

The Conformation of Neuroleptic Drugs

KOCH, M. H. J. (1974) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13925-4 · Cited by 21 · see citing works

Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.

Cj, N., & Janssen, P. A. (1974) · PubMed · Cited by 14 · see citing works

Butaclamol hydrochloride (AY-23,028): an early evaluation in severely ill schizophrenics.

Dh, M., Dm, G., Oelsner, T., et al. (1975) · PubMed · Cited by 11 · see citing works

Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine

Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156 · see citing works

The physiology, signaling, and pharmacology of dopamine receptors

Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763 · see citing works

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · see citing works

Schizophrenia

Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870 · see citing works

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia

Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831 · see citing works

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500 · see citing works

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035 · see citing works

Increased baseline occupancy of D ₂ receptors by dopamine in schizophrenia

Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020 · see citing works

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · see citing works

Glutamate and dopamine in schizophrenia: An update for the 21 ^st century

Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702 · see citing works

Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function

Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674 · see citing works

Half a century of antipsychotics and still a central role for dopamine D2 receptors

Kapur, S., & Mamo, D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.004 · Cited by 638 · see citing works

Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

Goto, Y., & Grace, A. A. (2005) · Nature Neuroscience · doi:10.1038/nn1471 · Cited by 576 · see citing works

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565 · see citing works

Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems

Ettenberg, A., Pettit, H. O., Bloom, F. E., & Koob, G. F. (1982) · Psychopharmacology · doi:10.1007/bf00428151 · Cited by 563 · see citing works

Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning

Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.023 · Cited by 520 · see citing works

Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function

Braver, T. S., Barch, D. M., & Cohen, J. D. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00116-x · Cited by 507 · see citing works

A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia

Simpson, E. H., Kellendonk, C., & Kandel, E. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.014 · Cited by 478 · see citing works

Disrupted prediction-error signal in psychosis: Evidence for an associative account of delusions

Corlett, P. R., Murray, G. K., Honey, G. D., Aitken, M. R. F., Shanks, D. R., Robbins, T. W., Bullmore, E. T., Dickinson, A., & Fletcher, P. C. (2007) · Brain · doi:10.1093/brain/awm173 · Cited by 460 · see citing works

Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets

Sesack, Sr., Aoki, C., & Pickel, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00088.1994 · Cited by 461 · see citing works

Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment

LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437 · see citing works

Delayed-Onset Hypothesis of Antipsychotic Action: A Hypothesis Tested and Rejected

Agid, O., Kapur, S., Arenovich, T., & Zipursky, R. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1228 · Cited by 408 · see citing works

Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia

Maynard, T. M., Sikich, L., Lieberman, J. A., & LaMantia, A.-S. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006887 · Cited by 383 · see citing works

Imaging endogenous dopamine competition with [¹¹C]raclopride in the human brain

Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379 · see citing works

Neurobiology of Dopamine in Schizophrenia

Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365 · see citing works

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336 · see citing works

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328 · see citing works

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

Kapur, S., & Remington, G. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.503 · Cited by 324 · see citing works

Selective D2 receptor actions on the functional circuitry of working memory

Wang, M., Vijayraghavan, S., & Goldman-Rakic, P. S. (2004) · Science · doi:10.1126/science.1091162 · Cited by 319 · see citing works

Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

Mailman, R., & Murthy, V. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361461 · Cited by 311 · see citing works

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works

How can drug discovery for psychiatric disorders be improved?

Agid, Y., Buzsáki, G., Diamond, D. M., Frackowiak, R., Giedd, J., Girault, J.-A., Grace, A., Lambert, J. J., Manji, H., Mayberg, H., et al. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2217 · Cited by 240 · see citing works

Dopamine hypothesis of schizophrenia: Making sense of it all

Toda, M., & Abi-Dargham, A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0041-7 · Cited by 235 · see citing works

From prediction error to psychosis: Ketamine as a pharmacological model of delusions

Corlett, P. R., Honey, G. D., & Fletcher, P. C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077716 · Cited by 227 · see citing works

Prepulse inhibition and genetic mouse models of schizophrenia

Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218 · see citing works

Circular inferences in schizophrenia

Jardri, R., & Denève, S. (2013) · Brain · doi:10.1093/brain/awt257 · Cited by 201 · see citing works

Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies

Abi-Dargham, A., & Laruelle, M. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.11.003 · Cited by 179 · see citing works

The Dopamine D₂, but not D₃or D₄, Receptor Subtype is Essential for the Disruption of Prepulse Inhibition Produced by Amphetamine in Mice

Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y.-M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., & Geyer, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04627.1999 · Cited by 174 · see citing works

Chapter 19 Dopamine, cognitive control, and schizophrenia: the gating model

Braver, T. S., & Cohen, J. D. (1999) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63082-4 · Cited by 159 · see citing works

Regulation of NMDA Receptors by Dopamine D₄Signaling in Prefrontal Cortex

Wang, X., Zhong, P., Gu, Z., & Yan, Z. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09852.2003 · Cited by 159 · see citing works

The natural history and pathophysiology of treatment resistant schizophrenia

Sheitman, B. B., & Lieberman, J. A. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00052-6 · Cited by 140 · see citing works

Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain

Kaalund, S. S., Newburn, E. N., Ye, T., Tao, R., Li, C., Deep-Soboslay, A., Herman, M. M., Hyde, T. M., Weinberger, D. R., Lipska, B. K., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.165 · Cited by 132 · see citing works

Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders

Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132 · see citing works

Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine

Kim, I. H., Rossi, M. A., Aryal, D. K., Racz, B., Kim, N., Uezu, A., Wang, F., Wetsel, W. C., Weinberg, R. J., Yin, H., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4015 · Cited by 127 · see citing works

Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson’s disease and schizophrenia

Ichinose, H., Ohye, T., Fujita, K., Pantucek, F., Lange, K., Riederer, P., & Nagatsu, T. (1994) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02250926 · Cited by 107 · see citing works

Understanding the Mechanism of Action of Atypical Antipsychotic Drugs: A Review of Compounds in Use and Development

Lieberman, J. A. (1993) · British Journal of Psychiatry · doi:10.1192/s0007125000292544 · Cited by 108 · see citing works

Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

de Bartolomeis, A., Buonaguro, E. F., & Iasevoli, F. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2921-8 · Cited by 89 · see citing works

D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex

Li, Y.-C., Kellendonk, C., Simpson, E. H., Kandel, E. R., & Gao, W.-J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109718108 · Cited by 78 · see citing works

The potential role of lamotrigine in schizophrenia

Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69 · see citing works

Cortical activity associated with auditory hallucinations

Ropohl, A., Sperling, W., Elstner, S., Tomandl, B., Reulbach, U., Kaltenhäuser, M., Kornhuber, J., & Maihöfner, C. (2004) · NeuroReport · doi:10.1097/00001756-200403010-00028 · Cited by 67 · see citing works

MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant

Shi, S., Leites, C., He, D., Schwartz, D., Moy, W., Shi, J., & Duan, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535203 · Cited by 61 · see citing works

D₂ but not D₃ receptors are elevated after 9 or 11 months chronic haloperidol treatment: Influence of withdrawal period

Joyce, J. N. (2001) · Synapse · doi:10.1002/syn.1035 · Cited by 47 · see citing works

Effect of spirulina maxima on the haloperidol induced tardive dyskinesia and oxidative stress in rats

Thaakur, S. R., & Jyothi, B. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0744-2 · Cited by 44 · see citing works

Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET

Bolding, M. S., White, D. M., Hadley, J. A., Weiler, M., Holcomb, H. H., & Lahti, A. C. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00105 · Cited by 41 · see citing works

The Novel Antipsychotic Drug Lurasidone Enhances N-Methyl-d-aspartate Receptor-Mediated Synaptic Responses

Yuen, E. Y., Li, X., Wei, J., Horiguchi, M., Meltzer, H. Y., & Yan, Z. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076141 · Cited by 38 · see citing works

Reduced crowding and poor contour detection in schizophrenia are consistent with weak surround inhibition

Robol, V., Tibber, M. S., Anderson, E. J., Bobin, T., Carlin, P., Shergill, S. S., & Dakin, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060951 · Cited by 37 · see citing works

Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions

Golan, M., Schreiber, G., & Avissar, S. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168038 · Cited by 22 · see citing works

MicroRNAs in schizophrenia: implications for synaptic plasticity and dopamine–glutamate interaction at the postsynaptic density. New avenues for antipsychotic treatment under a theranostic perspective

de Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21 · see citing works

Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure

Wang, X., Gu, Z., Zhong, P., Chen, G., Feng, J., & Yan, Z. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.08.018 · Cited by 16 · see citing works

Computational Models of Hallucinations

Jardri, R., & Denève, S. (2013) · The Neuroscience of Hallucinations · doi:10.1007/978-1-4614-4121-2_16 · Cited by 16 · see citing works

The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration

Norman, A. B., Tabet, M. R., Norman, M. K., Fey, B. K., Tsibulsky, V. L., & Millard, R. W. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183244 · Cited by 10 · see citing works

The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor

Wang, X., Wang, Z.-B., Luo, C., Mao, X., Li, X., Yin, J., Zhang, W., Zhou, H., & Liu, Z. (2019) · Journal of Cancer · doi:10.7150/jca.27780 · Cited by 84 · see citing works

Dopamine antagonists induce gastric lesions in rats

Sikirić, P., Geber, J., Ivanovic, D., et al. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90522-4 · Cited by 37 · see citing works

ChemInform Abstract: Dopamine Receptors: Studies on Structure and Function

Strange, P. G. (1996) · ChemInform · doi:10.1002/chin.199642295 · Cited by 1 · see citing works

Electrooculographic and electroretinographic study in the chicken after dopamine and haloperidol

Wioland, N., Rudolf, G., & Bonaventure, N. (1990) · Documenta Ophthalmologica · doi:10.1007/bf00146553 · Cited by 26 · see citing works

Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors

Myslivecek, J. (2022) · Life · doi:10.3390/life12050606 · Cited by 20 · see citing works